PL365249A1 - Nowe pochodne heteroarylowe, sposób ich wytwarzania i zastosowanie - Google Patents
Nowe pochodne heteroarylowe, sposób ich wytwarzania i zastosowanieInfo
- Publication number
- PL365249A1 PL365249A1 PL02365249A PL36524902A PL365249A1 PL 365249 A1 PL365249 A1 PL 365249A1 PL 02365249 A PL02365249 A PL 02365249A PL 36524902 A PL36524902 A PL 36524902A PL 365249 A1 PL365249 A1 PL 365249A1
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- heteroaryl derivatives
- novel heteroaryl
- disorders
- disorder
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Addiction (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200101036 | 2001-06-29 | ||
| PCT/DK2002/000435 WO2003002556A1 (en) | 2001-06-29 | 2002-06-27 | Novel heteroaryl derivatives, their preparation and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL365249A1 true PL365249A1 (pl) | 2004-12-27 |
Family
ID=8160598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02365249A PL365249A1 (pl) | 2001-06-29 | 2002-06-27 | Nowe pochodne heteroarylowe, sposób ich wytwarzania i zastosowanie |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US20040248883A1 (pl) |
| EP (1) | EP1399438B1 (pl) |
| JP (1) | JP2004535449A (pl) |
| KR (1) | KR20040019026A (pl) |
| CN (1) | CN1310909C (pl) |
| AT (1) | ATE312094T1 (pl) |
| AU (1) | AU2002344949B2 (pl) |
| BG (1) | BG108531A (pl) |
| BR (1) | BR0210401A (pl) |
| CA (1) | CA2451228A1 (pl) |
| CZ (1) | CZ2004156A3 (pl) |
| DE (1) | DE60207857T2 (pl) |
| DK (1) | DK1399438T3 (pl) |
| EA (1) | EA006203B1 (pl) |
| ES (1) | ES2252471T3 (pl) |
| HU (1) | HUP0400344A2 (pl) |
| IL (1) | IL158828A0 (pl) |
| IS (1) | IS2425B (pl) |
| MX (1) | MXPA03011769A (pl) |
| NO (1) | NO326514B1 (pl) |
| NZ (1) | NZ529460A (pl) |
| PL (1) | PL365249A1 (pl) |
| SI (1) | SI1399438T1 (pl) |
| SK (1) | SK652004A3 (pl) |
| UA (1) | UA75407C2 (pl) |
| WO (1) | WO2003002556A1 (pl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20040019027A (ko) * | 2001-06-29 | 2004-03-04 | 하. 룬트벡 아크티에 셀스카브 | 신규한 인돌 유도체 |
| ES2323451T7 (es) | 2001-07-20 | 2011-08-01 | Psychogenics Inc. | Tratamiento para el trastorno de hiperactividad con deficit de atencion. |
| AU2004256124B2 (en) * | 2003-07-02 | 2011-04-28 | Corus Pharma, Inc. | Aztreonam L-lysine and methods for the preparation thereof |
| US7160888B2 (en) | 2003-08-22 | 2007-01-09 | Warner Lambert Company Llc | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
| JP2008521771A (ja) | 2004-11-26 | 2008-06-26 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 改良された抗精神病活性および抗不安症活性を有するイソキサゾリン−インドール誘導体 |
| US20120283434A1 (en) | 2010-01-04 | 2012-11-08 | Enantia, S.L. | Process for the preparation of rivaroxaban and intermediates thereof |
| CN102858808B (zh) | 2010-04-12 | 2015-04-01 | 乐天化学株式会社 | 用于烯烃聚合的负载型催化剂以及利用该催化剂的聚烯烃的制备方法 |
| EP2559710B1 (en) | 2010-04-12 | 2016-07-13 | Lotte Chemical Corporation | Catalyst composition for polymerizing olefin and method for preparing polyolefin using same |
| WO2011129594A2 (ko) | 2010-04-12 | 2011-10-20 | 호남석유화학 주식회사 | 티오펜-축합고리 사이클로펜타디에닐 리간드를 포함하는 전이금속 화합물을 사용한 올레핀-디엔 공중합체의 제조방법 |
| KR100986301B1 (ko) | 2010-04-12 | 2010-10-07 | 아주대학교산학협력단 | 테트라하이드로퀴놀린 유도체로부터 유래한 티오펜-축합고리 싸이클로펜타디에닐 4족 금속 화합물 및 이를 이용한 올레핀 중합 |
| KR101384450B1 (ko) | 2010-04-12 | 2014-04-25 | 롯데케미칼 주식회사 | 티오펜-축합고리 사이클로펜타디에닐 리간드를 포함하는 전이금속 화합물을 사용한 올레핀-디엔 공중합체의 제조방법 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2667068B1 (fr) * | 1990-09-26 | 1994-09-09 | Adir | Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| KR20040019027A (ko) * | 2001-06-29 | 2004-03-04 | 하. 룬트벡 아크티에 셀스카브 | 신규한 인돌 유도체 |
-
2002
- 2002-06-27 MX MXPA03011769A patent/MXPA03011769A/es active IP Right Grant
- 2002-06-27 AU AU2002344949A patent/AU2002344949B2/en not_active Ceased
- 2002-06-27 BR BR0210401-6A patent/BR0210401A/pt not_active IP Right Cessation
- 2002-06-27 ES ES02742849T patent/ES2252471T3/es not_active Expired - Lifetime
- 2002-06-27 US US10/482,764 patent/US20040248883A1/en not_active Abandoned
- 2002-06-27 IL IL15882802A patent/IL158828A0/xx unknown
- 2002-06-27 NZ NZ529460A patent/NZ529460A/en unknown
- 2002-06-27 JP JP2003508937A patent/JP2004535449A/ja active Pending
- 2002-06-27 EA EA200400102A patent/EA006203B1/ru not_active IP Right Cessation
- 2002-06-27 DK DK02742849T patent/DK1399438T3/da active
- 2002-06-27 HU HU0400344A patent/HUP0400344A2/hu unknown
- 2002-06-27 CZ CZ2004156A patent/CZ2004156A3/cs unknown
- 2002-06-27 EP EP02742849A patent/EP1399438B1/en not_active Expired - Lifetime
- 2002-06-27 DE DE60207857T patent/DE60207857T2/de not_active Expired - Fee Related
- 2002-06-27 CN CNB028129946A patent/CN1310909C/zh not_active Expired - Fee Related
- 2002-06-27 UA UA20031211984A patent/UA75407C2/uk unknown
- 2002-06-27 KR KR10-2003-7017125A patent/KR20040019026A/ko not_active Abandoned
- 2002-06-27 CA CA002451228A patent/CA2451228A1/en not_active Abandoned
- 2002-06-27 SK SK65-2004A patent/SK652004A3/sk unknown
- 2002-06-27 AT AT02742849T patent/ATE312094T1/de not_active IP Right Cessation
- 2002-06-27 PL PL02365249A patent/PL365249A1/pl unknown
- 2002-06-27 WO PCT/DK2002/000435 patent/WO2003002556A1/en not_active Ceased
- 2002-06-27 SI SI200230265T patent/SI1399438T1/sl unknown
-
2003
- 2003-11-10 IS IS7021A patent/IS2425B/is unknown
- 2003-12-18 NO NO20035673A patent/NO326514B1/no unknown
-
2004
- 2004-01-14 BG BG108531A patent/BG108531A/bg unknown
-
2007
- 2007-06-05 US US11/758,511 patent/US7393845B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RS20120158A3 (en) | Phenyl-piperazine Derivatives As Serotonin Resorption Inhibitors | |
| WO2002064594A3 (en) | 6-substituted pyrido-pyrimidines | |
| YU63202A (sh) | Derivati 2-okso-1-pirolidina, postupci za njihovo dobijanje i njihove upotrebe | |
| MXPA04005456A (es) | Derivados de acetileno que tienen actividad antagonistica de mglur5. | |
| IL248993A0 (en) | erbb inhibitors | |
| MXPA03010232A (es) | Compuestos de arilsulfonamida, para el tratamiento de la obesidad, de la diabetes tipo ii y de trastornos del sistema nervioso central. | |
| MXPA06001647A (es) | 6-(2, 2, 2-trifluoroetilamino) -7-cloro-2, 3, 4, 5-tetrahidro- 1h-benzo[d] azepina como un agonista del receptor 5-ht2c. | |
| PL371127A1 (pl) | Pochodne 6-amino-morfinianu, metody ich otrzymywania oraz ich zastosowania | |
| WO2002085896A8 (en) | Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan | |
| IL158828A0 (en) | Novel heteroaryl derivatives, their preparation and use | |
| SI1626720T1 (sl) | Derivati 4-(2-fenilsulfanil-fenil)-piperidina kotzaviralci ponovnega vnosa serotonina | |
| TW200745039A (en) | Isotopically substituted pantoprazole | |
| DE60213576D1 (de) | ANTIDEPRESSIVE AZAHETEROCYCLYLMETHYL-DERIVATE VON 2,3-DIHYDRO-1,4-DIOXINOi2,3-föCHINOXALIN | |
| MXPA03011766A (es) | Novedosos derivados de indol. | |
| PT1392700E (pt) | Derivados aza-heterociclilmetilo antidepressivos de 7,8-di-hidro-1,6,9-troxa-3-aza-ciclopenta(a)naftaleno | |
| MXPA05010678A (es) | Derivados de 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridina como inhibidores de recaptacion de serotonina. | |
| DE60204882D1 (de) | Zykloalkenylsulfonamidderivate | |
| MXPA04005151A (es) | Compuestos terapeuticos. | |
| ATE265418T1 (de) | Neue substituierte 3-phenoxy- und 3- phenylalkyloxy-2-phenyl-propylamine | |
| UA85198C2 (ru) | Производные морфолина как ингибиторы повторного поглощения норэпинефрина |